16 million for clinical research on tandem therapy

2020.03.27 9:54 - Marek Pawłowski

The Project „The use of the LutaPol/ItraPol (177Lu/90Y-DOTATATE) tandem therapy as an effective tool for the treatment of neuroendocrine tumors” coordinated by POLATOM was eligible for funding in the Medical Research Agency’s competition to support non-commercial clinical research.